APA (7th ed.) Citation

LN, I., DG, B., AV, L., R, Ș., A, L., CG, S., . . . DM, M. (2025). Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients. Molecular and cellular biochemistry, 480(3), 1645. https://doi.org/10.1007/s11010-024-05076-z

Chicago Style (17th ed.) Citation

LN, Ionică, et al. "Empagliflozin and Dapagliflozin Decreased Atrial Monoamine Oxidase Expression and Alleviated Oxidative Stress in Overweight Non-diabetic Cardiac Patients." Molecular and Cellular Biochemistry 480, no. 3 (2025): 1645. https://doi.org/10.1007/s11010-024-05076-z.

MLA (9th ed.) Citation

LN, Ionică, et al. "Empagliflozin and Dapagliflozin Decreased Atrial Monoamine Oxidase Expression and Alleviated Oxidative Stress in Overweight Non-diabetic Cardiac Patients." Molecular and Cellular Biochemistry, vol. 480, no. 3, 2025, p. 1645, https://doi.org/10.1007/s11010-024-05076-z.